Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for c…
The bill requires the HHS Inspector General to study CMS processes for adding, modifying, and removing Medicare billing codes and report findings and recommendations to Congress within 12 months. It also requires annual public reports, beginning 2025, listing billing codes added in the prior year with associated Medicare volume and expenditures.
Progressives emphasize outcomes, equity, and protecting access
Relative to its intended legislative type, this bill is a clear, narrowly scoped study/reporting measure that assigns responsibility and deadlines for an OIG study and ongoing HHS reporting.
The bill requires the HHS Inspector General to study CMS processes for adding, modifying, and removing Medicare billing codes and report findings and recommendations to Congress within 12 months.
It also requires annual public reports, beginning 2025, listing billing codes added in the prior year with associated Medicare volume and expenditures.
Content is low-risk and administratively focused, so it has reasonable bipartisan appeal, but many noncontroversial bills still stall without sponsors' leverage or package inclusion.
Relative to its intended legislative type, this bill is a clear, narrowly scoped study/reporting measure that assigns responsibility and deadlines for an OIG study and ongoing HHS reporting. It provides useful topical specificity for the study and concrete reporting timelines.
Progressives emphasize outcomes, equity, and protecting access
These are examples from the analysis, not a ranked list of the most-affected groups.
Progressives emphasize outcomes, equity, and protecting access
Generally supportive of increased transparency and oversight to protect patients and government spending.
Concerned that findings could be used to justify cuts unless reports emphasize outcomes, equity, and access protections.
Views the OIG study as a tool to surface disparities and cost drivers.
Supportive in principle as a pragmatic oversight measure offering better data for policymaking.
Wants clarity on costs, timelines, and resources for implementation to avoid unfunded mandates.
Sees value if the study leads to targeted, evidence-based reforms.
Generally supportive of oversight and transparency as tools to control Medicare spending and increase accountability.
Wary of creating new bureaucratic procedures or using the study to restrict access or slow adoption of medical innovations.
Prefers limits preventing mission creep.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Content is low-risk and administratively focused, so it has reasonable bipartisan appeal, but many noncontroversial bills still stall without sponsors' leverage or package inclusion.
The bill has not accumulated any surfaced votes yet.
Progressives emphasize outcomes, equity, and protecting access
Content is low-risk and administratively focused, so it has reasonable bipartisan appeal, but many noncontroversial bills still stall witho…
Relative to its intended legislative type, this bill is a clear, narrowly scoped study/reporting measure that assigns responsibility and deadlines for an OIG study and ongoing HHS reporting. It provides useful topical s…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.